Sugentech
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Sugentech develops and manufactures diagnostic test kits and devices that detect diseases or health conditions, including rapid point-of-care tests that deliver results at the bedside or clinic rather than in a central lab, and multiplex immunoblot tests that screen for multiple conditions at once.
Its products are used by healthcare providers and, through home-test formats, by individual consumers. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company is expanding beyond diagnostics into personalised health and beauty products by combining its diagnostic technology with artificial-intelligence analysis.
Summary is AI-generated and may contain errors · figures from DART filings
Sugentech in five facts
What does Sugentech do?
Sugentech develops and manufactures diagnostic test kits and devices that detect diseases or health conditions, including rapid point-of-care tests that deliver results at the bedside or clinic rather than in a central lab, and multiplex immunoblot tests that screen for multiple conditions at once.
Where is Sugentech listed and in which sector?
Sugentech (Korean name: 수젠텍) trades under KRX code 253840 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is Sugentech?
Its market capitalisation was US$54.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Sugentech's latest annual revenue and operating profit?
For fiscal year 2025, Sugentech reported revenue of US$7.1M, an operating loss of US$14.2M and a net loss of US$17.7M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was down 6.7% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.